Hewei Li
Impact in
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 2
-
- RNA Interference and Gene Delivery 2
- Co-authors
- Frank Stephen Hodi (2 shared papers)James Larkin (2 shared papers)Jeffrey S. Weber (2 shared papers)Joel Jiang (1 shared paper)Georgina Venetia Long (1 shared paper)Dirk Schadendorf (1 shared paper)Jedd D. Wolchok (1 shared paper)Caroline Robert (1 shared paper)
- Journals
- Alzheimer s & Dementia (4 papers)Frontiers in Plant Science (2 papers)British Journal of Clinical Pharmacology (1 paper)Nutrients (1 paper)Plant Science (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Hewei Li
35 papers receiving 1.9k citations
Hewei Li's Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 1.1k
- Genetics 129
- Immunology 231
- Pulmonary and Respiratory Medicine 245
- Complementary and alternative medicine 60
Countries citing papers authored by Hewei Li
This map shows the geographic impact of Hewei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hewei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hewei Li more than expected).
Fields of papers citing papers by Hewei Li
This network shows the impact of papers produced by Hewei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hewei Li. The network helps show where Hewei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Hewei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma Hit paper breakdown → | 2017 | 986 |
| 2 | 2017 | 230 | |
| 3 | 2012 | 118 | |
| 4 | Intracerebral adenovirus-mediated p53 tumor suppressor gene therapy for experimental human glioma. | 1999 | 65 |
| 5 | 2012 | 61 | |
| 6 | 2014 | 60 | |
| 7 | 2020 | 58 | |
| 8 | 1999 | 50 | |
| 9 | 2012 | 41 | |
| 10 | 1997 | 37 | |
| 11 | 2012 | 32 | |
| 12 | 2016 | 27 | |
| 13 | 2014 | 17 | |
| 14 | 2022 | 15 | |
| 15 | 2019 | 15 | |
| 16 | 2012 | 15 | |
| 17 | 2021 | 14 | |
| 18 | 2021 | 14 | |
| 19 | 2022 | 12 | |
| 20 | 2017 | 11 |
About Hewei Li
Hewei Li is a scholar working on Oncology, Molecular Biology, Cancer Research, Physiology and Pharmacology, having authored 37 papers that have together received 1.9k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (4 papers), Cancer-related molecular mechanisms research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer Research and Treatments (2 papers), CAR-T cell therapy research (2 papers), Vagus Nerve Stimulation Research (2 papers), Plant Molecular Biology Research (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Oncology (1.1k citations), Genetics (129 citations), Immunology (231 citations), Pulmonary and Respiratory Medicine (245 citations) and Complementary and alternative medicine (60 citations). Hewei Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Frank Stephen Hodi, James Larkin, Jeffrey S. Weber, Joel Jiang, Georgina Venetia Long, Dirk Schadendorf, Jedd D. Wolchok, Caroline Robert, Mario Sznol and Suzanne Louise Topalian. Their work appears in journals such as Alzheimer s & Dementia, Frontiers in Plant Science, British Journal of Clinical Pharmacology, Nutrients and Plant Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.